Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study.
Thomas ButtgereitSophie GuLeonor Carneiro-LeãoAnnika GutscheMarcus MaurerFrank SiebenhaarPublished in: Allergy (2022)
Mast cell activation syndrome was confirmed in only 2% of patients, which implies that it is not MC activation that drives signs and symptoms in most patients with suspected MCAS. There is a high need for comprehensive research efforts aimed at the identification of the true underlying pathomechanism(s) in patients with suspected MCAS.